Pallawi Torka

31PUBLICATIONS
281CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Immunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 07, 2026
Racial/ethnic disparities in risk of second primary malignancies among Diffuse Large B-cell Lymphoma survivors.

|Jul 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Feb 24, 2026
Inclusion, characteristics, and reporting of older patients in recent registration trials for DLBCL.

Nina Rosa Neuendorff, Kelly Pugh, Ronit Juthani

Pageof 6

Frequent Collaborators

12 joint publications

Narendranath Epperla

9 joint publications

Reem Karmali

7 joint publications

Kevin David

5 joint publications

Geoffrey Shouse